More than £10 million in NHS funding will be spent on new research into children’s gender care including the use of puberty blockers.
Plans for a trial were announced last year following the publication of the Cass Review which concluded the quality of studies claiming to show beneficial effects of such medication for children and young people with gender dysphoria was “poor”.
